ArticleBMC geriatrics2025
Enhanced machine learning models for predicting three-year mortality in Non-STEMI patients aged 75 and above.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundNon-ST segment elevation myocardial infarction (Non-STEMI) is a severe cardiovascular condition mainly affecting individuals aged 75 and above, who are at higher risk of mortality due to age-related vulnerabilities and other health issues. Current prognostic models are often inadequate in addressing the complexity of this population. This study aims to develop and validate a machine learning (ML) model to predict three-year mortality in Non-STEMI patients aged 75 and above, to assist clinicians in decision-making.
methodsClinical data from 234 Non-STEMI patients aged 75 and above were collected and split into a training cohort (164 patients) and a validation cohort (70 patients) using a 70:30 ratio. Six key factors-age, Pulse (P, beats per minute), respiratory support rate, Glucose (Glu) levels, percutaneous coronary intervention (PCI), and β-blocker use-were identified as significantly associated with three-year mortality through LASSO regression and ten-fold cross-validation. The Random Forest (RF) model was employed for prediction, which yielded the best performance with an area under the curve (AUC) of 0.92. SHapley Additive exPlanations (SHAP) analysis was used to determine the top contributing features influencing mortality, with PCI, age, and P(bpm) identified as the most critical factors. A web-based calculator was also developed to support clinical decision-making.
resultsThe RF model demonstrated the best predictive performance (AUC = 0.92), significantly outperforming other models. Key features, such as PCI, age, and P(bpm), were found to be highly influential in predicting three-year mortality. The developed web-based tool offers clinicians a user-friendly platform to incorporate these findings into personalized care decisions.
conclusionsThis study presents a robust RF model for predicting three-year mortality in Non-STEMI patients aged 75 and above. PCI, β-blocker use, and effective management of P(bpm) and Glu levels are crucial factors for improving patient outcomes. The web-based tool enhances personalized decision-making, helping clinicians better allocate resources and provide tailored interventions for this at-risk population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.